Showing 13,641 - 13,660 results of 24,414 for search '(( a step decrease ) OR ( 100 ((((we decrease) OR (mean decrease))) OR (a decrease)) ))', query time: 0.85s Refine Results
  1. 13641

    NTS_QECH by Catherine Wilson (8586315)

    Published 2022
    “…Estimated minimum incidence of iNTS disease decreased from 21/100,000 per year in 2011 to 7/100,000 per year in 2019. …”
  2. 13642

    Table_1_Dupilumab effectively and rapidly treats bullous pemphigoid by inhibiting the activities of multiple cell types.docx by Tianmeng Yan (16682754)

    Published 2023
    “…Dupilumab has emerged as an alternative option for BP patients.</p>Objective<p>We evaluated the efficiency and safety of dupilumab on BP treatment and explored a mode of drug action in depth.…”
  3. 13643

    Table_3_Dupilumab effectively and rapidly treats bullous pemphigoid by inhibiting the activities of multiple cell types.xlsx by Tianmeng Yan (16682754)

    Published 2023
    “…Dupilumab has emerged as an alternative option for BP patients.</p>Objective<p>We evaluated the efficiency and safety of dupilumab on BP treatment and explored a mode of drug action in depth.…”
  4. 13644

    Table_1_Dupilumab effectively and rapidly treats bullous pemphigoid by inhibiting the activities of multiple cell types.docx by Tianmeng Yan (16682754)

    Published 2023
    “…Dupilumab has emerged as an alternative option for BP patients.</p>Objective<p>We evaluated the efficiency and safety of dupilumab on BP treatment and explored a mode of drug action in depth.…”
  5. 13645

    DataSheet_1_Dupilumab effectively and rapidly treats bullous pemphigoid by inhibiting the activities of multiple cell types.docx by Tianmeng Yan (16682754)

    Published 2023
    “…Dupilumab has emerged as an alternative option for BP patients.</p>Objective<p>We evaluated the efficiency and safety of dupilumab on BP treatment and explored a mode of drug action in depth.…”
  6. 13646

    Table_2_Dupilumab effectively and rapidly treats bullous pemphigoid by inhibiting the activities of multiple cell types.xlsx by Tianmeng Yan (16682754)

    Published 2023
    “…Dupilumab has emerged as an alternative option for BP patients.</p>Objective<p>We evaluated the efficiency and safety of dupilumab on BP treatment and explored a mode of drug action in depth.…”
  7. 13647

    Table_3_Dupilumab effectively and rapidly treats bullous pemphigoid by inhibiting the activities of multiple cell types.xlsx by Tianmeng Yan (16682754)

    Published 2023
    “…Dupilumab has emerged as an alternative option for BP patients.</p>Objective<p>We evaluated the efficiency and safety of dupilumab on BP treatment and explored a mode of drug action in depth.…”
  8. 13648

    DataSheet_1_Dupilumab effectively and rapidly treats bullous pemphigoid by inhibiting the activities of multiple cell types.docx by Tianmeng Yan (16682754)

    Published 2023
    “…Dupilumab has emerged as an alternative option for BP patients.</p>Objective<p>We evaluated the efficiency and safety of dupilumab on BP treatment and explored a mode of drug action in depth.…”
  9. 13649

    Data Sheet 1_Neutrophil extracellular traps and macrophage activation contibute to thrombosis and post-covid syndrome in SARS-CoV-2 infection.pdf by Irene Serrano-Gonzalo (9408128)

    Published 2025
    “…NETs markers (myeloperoxidase (MPO), neutrophil elastase (NE), p-selectin (P-SEL) and S100A8/S100A9 heterodimer (MRP)) and macrophage activation markers (Chitotriosidase activity (ChT), CCL18/PARC and YKL-40) were measured.…”
  10. 13650

    Effect of broad-spectrum potassium channel blockers on evoked DA overflow. by Philippe Martel (350692)

    Published 2013
    “…(E) After a 30 min application of 100 µM 4-AP, 1 µM ConoTX was applied and caused a ∼ 90% decrease in evoked DA release. …”
  11. 13651

    Effect of the overexpression of Mfn2 or the truncated Mfn2 mutant on mitochondrial function in GCDCA-treated L02 cells. by Yongbiao Chen (418836)

    Published 2013
    “…The results are expressed as a percentage of the control value, which was set at 100%. …”
  12. 13652

    Data Sheet 2_Characterization and immunoprotection of thioredoxin reductase TrxB knockout mutant of Salmonella Enteritidis.pdf by Siping Zhu (607538)

    Published 2025
    “…We also observed a significant decrease in the expression of virulence-related genes in the trxB-knockout mutant. …”
  13. 13653

    Data Sheet 4_Characterization and immunoprotection of thioredoxin reductase TrxB knockout mutant of Salmonella Enteritidis.pdf by Siping Zhu (607538)

    Published 2025
    “…We also observed a significant decrease in the expression of virulence-related genes in the trxB-knockout mutant. …”
  14. 13654

    Data Sheet 3_Characterization and immunoprotection of thioredoxin reductase TrxB knockout mutant of Salmonella Enteritidis.pdf by Siping Zhu (607538)

    Published 2025
    “…We also observed a significant decrease in the expression of virulence-related genes in the trxB-knockout mutant. …”
  15. 13655

    Data Sheet 5_Characterization and immunoprotection of thioredoxin reductase TrxB knockout mutant of Salmonella Enteritidis.pdf by Siping Zhu (607538)

    Published 2025
    “…We also observed a significant decrease in the expression of virulence-related genes in the trxB-knockout mutant. …”
  16. 13656

    Data Sheet 1_Characterization and immunoprotection of thioredoxin reductase TrxB knockout mutant of Salmonella Enteritidis.pdf by Siping Zhu (607538)

    Published 2025
    “…We also observed a significant decrease in the expression of virulence-related genes in the trxB-knockout mutant. …”
  17. 13657

    Effects of hormone therapy and high-fat diet on microglia in female mice. by Amy Christensen (4062937)

    Published 2017
    “…Scale bar in (A) measure 20 μm and in (D) measures 100 μm.</p>…”
  18. 13658

    No expression of eMHC in RFs and attenuation of ongoing muscle regeneration in aged <i>mdx</i> and <i>mdx52</i> mice. by Yusuke Echigoya (437052)

    Published 2013
    “…Values are mean ± S.D. (<i>n</i> = 3–6 mice per group). A significant decrease in the number of eMHC-positive fibers is found only at 18<b> </b>months old in <i>mdx</i> mice (**<i>P</i><0.01 compared to 2<b> </b>months old, †<i>P</i><0.05 compared to 6 and 12<b> </b>months old). …”
  19. 13659

    Effects of Gu-4 on survival and expression profiles of TNF-α and IL-10 in septic mice. by TingTing Yan (5652595)

    Published 2013
    “…Gu-4 administration significantly reduced LPS-induced mortality at the doses of 0.88, 1.06, 1.27 and 1.53 mg/kg. *: p<0.05 indicates a significant decrease in mortality by Gu-4 treatment versus saline treatment as determined by log-rank test. β-lactose or dexamethasone (Dex) did not produce significant improvement in survival. …”
  20. 13660

    Cartilage and subchondral bone degeneration scores at 7 and 12 wks after the start of the experiment. by Junya Sakamoto (4286575)

    Published 2023
    “…<p><b>A:</b> a, b and c; Representative toluidine blue staining of each group at 7 wks after the start of experiment. …”